News

Researchers identify transcription factors and environmental conditions necessary to reprogram human and mouse cells into cells that function like hematopoietic stem cells.

China's food and drug authority has approved a clinical trial of human blood protein cultivated in transgenic rice seeds, which could lead to large-scale production of much-needed blood plasma.

The stem cells that produce our blood have been created in the lab for the first time. These could one day be used to treat people who have blood diseases and leukaemia with their own cells, rather than bone marrow transplants from a donor. They could also be used to create blood for transfusions.